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Since the discovery of Australia antigen, Au(1), by Blumberg et al. in 1965 (1) the 
association of this antigen with viral hepatitis has been well established  (2-4). Au(1) 
is present in 58% of patients  with posttransfusion hepatitis  and in 38% of patients 
with infectious hepatitis (5). When patients are tested serially after blood transfusion, 
the incidence of Au(1)  was found to be  74%  (6).  In most acute cases,  the  antigen 
appears  in  the  blood early in the  disease  and  disappears  within  2-3  wk  as clinical 
improvement occurs. 
In  addition  to  the  epidemiologic  association,  there  are  several  findings  which 
provide strong support for the hypothesis that Au(1) is an antigenic determinant of a 
virus capable of causing hepatitis.  (a) Purified Au(1), isolated from serum of patients 
with  hepatitis,  consists  of virus-like particles,  200  A  in diameter,  which are  agglu- 
tinated  by specific  anti-Au(1)  antiserum  (7).  (b)  Patients  who have  received blood 
containing  Au(1)  have  developed hepatitis  with  Au(1)  in their  blood  or remained 
healthy and developed antibody to Au(1) (4).  (c) With the use of a specific fluorescein- 
conjugated antibody to Au(1) we were able to demonstrate fluorescent granules in or 
on the surface of nuclei of cells from liver tissue in four patients with hepatitis  and 
Au(1) in their serum. Five control patients who had neither hepatitis nor serum Au(1) 
did  not have  fluorescent  granules  (8). 
The  purpose  of the  present  study  is  to  determine  whether  the  fluorescent 
particles in liver tissue are associated with Au(1) in the blood and whether the 
particles  are  present  in  tissues  other  than  liver.  This  study  involves 61  liver 
biopsy specimens,  25  specimens  of other human  tissues,  cells  from 8  samples 
of bile  or  duodenal  drainage  and  peripheral  lymphocyte cultures  from 8  pa- 
tients.  This  study confirms our previous  results  and establishes:  (a)  that  the 
fluorescent  particles  in the cells  are related  to Au(1)  in the serum  and to the 
diagnosis of hepatitis.  (b)  The fluorescent particles are present in tissues  other 
than liver in some patients. 
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Materials and Methods 
Collection of Specimens.--61  liver biopsy specimens were obtained from 58  patients in 
hospitals in the Philadelphia area and one from elsewhere. 1 In 57 cases needle biopsies were 
performed using a Menghini needle. Two liver specimens  were obtained at surgery and two at 
autopsy. Two patients had a  second biopsy performed 4-6 wk after the initial biopsy. The 
second specimen in each case was treated and recorded as a separate specimen for statistical 
analysis. Eight bone marrow specimens were obtained by needle aspiration of the sternum. 
The  other tissues were obtained from organs removed at  surgery for therapeutic reasons. 
Buffy coat smears and peripheral lymphocytes were obtained from patients in our Clinical 
Research Unit. Seminal fluid was obtained from one patient with acute hepatitis who also had 
Au(1)  in his serum. A blood sample was obtained from each patient at the time of liver biopsy 
or collection of other specimens. 
One patient in our Clinical  Research Unit was studied in detail and will be reported else- 
where (9). He was a  21  year old male (D.M.) with Down's syndrome and chronic hepatitis 
and Au(1)  in his blood who later developed acute myelogenous leukemia. A  bone marrow 
specimen was obtained 3 wk prior to death, and immediately after death specimens of liver, 
spleen, mesentery, and testis were taken. 
Preparation of Tissues for Examination.--Each  tissue specimen was placed  in  a  small 
volume of McCoy's 5a tissue culture medium (Grand Island Biological  Co.,  Grand Island, 
N.Y.)  containing 30% newborn calf serum (Hyland Laboratories, Los Angeles, Calif.)  and 
was minced to produce a cell suspension.  2 A drop of the cell suspension was placed on a clean 
slide,  air-dried and fixed  in acetone at room temperature for 10 min? At the same time, a 
piece of tissue was placed in formalin and processed for routine histologic examination by the 
clinical pathology departments of the respective hospitals. The bone marrow specimens were 
prepared by placing a drop of the marrow directly on a glass slide,  air-drying and fixing as 
above. Cells were obtained from bile, duodenal drainage, and seminal fluid by centrifugation 
for 10 rain in a  clinical  centrifuge, washing the cell pellet in Earle's balanced salt solution 
(Grand  Island Biological  Co.),  resuspending in McCoy's medium, and preparing slides as 
above. Buffy coat smears were made from peripheral blood and fixed in acetone for 10 rain. 
Peripheral lymphocyte cultures were prepared by the method of Hungerford (10) with the 
omission  of  colchicine. 
Preparation of Reagent and Staining of Slides.--Fluorescein-conjugated  rabbit anti-Au(1) 
antiserum was prepared and direct fluorescent staining of slides was performed by the methods 
previously published (8).  Replicate slides were stained with fluorescein-conjugated goat vs. 
human antiserum and goat-vs.-rabbit antiserum to test the specificity of the reaction. In- 
direct staining was performed by flooding  the slides with uncon~ugated  rabbit  anti-Au(1) 
antiserum, washing in buffered saline,  and then applying fluorescein-labeled goat-vs.-rabbit 
anti-globulin antiserum. Control slides for the indirect test were treated first with normal 
rabbit serum in place of the anti-Au(1) antiserum before the application of conjugated goat- 
vs.-rabbit anti-globulin antiserum. 
1 These include: The American Oncologic  Hospital, Children's Hospital of Philadelphia' 
the Hospital of the University of Pennsylvania, Jeanes Hospital, Jefferson Medical College 
Hospital, Philadelphia General Hospital, Pennsylvania Hospital, Temple University Hospital, 
the Philadelphia Veterans Administration Hospital, and Woman's Medical College Hospital. 
One case was obtained from the Strong Memorial Hospital, Rochester, New York. 
o McCoy's medium alone or buffered saline, pH 7.4, were used in some cases and produced 
similar results. 
3 We have tried direct tissue impressions on many liver specimens in the past and found 
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Testing of Serum.--Serum from each patient was tested for the presence of Au(1)  by double 
diffusion in agar gel (Ouchterlony method), using a panel of anti-Au(1) antisera consisting of 
rabbit, mouse, and human antisera (11). 
Examination  of Slides.--Slides were examined for fluorescence  in dark field using a Zeiss 
microscope with the HBO 200 watt illuminator, BG 12 exciter filter, and 53 barrier filter. All 
slides were read by one of us (V.C.) without knowledge of the histologic diagnosis or the serum 
results for Au(1).  The reproducibility of results was established by examining duplicate slides 
from the same patients and by reading the same slides on different days. To test the accuracy 
of reading, 10 slides were chosen at  random and coded. They were read by V.C. and I.M. 
independently. The correlation between the two observers was 100%. 
RESULTS 
I.  Liver Biopsies 
Appearance  of Fluorescence.--When  tested  by the  direct  method,  the liver 
biopsies could be divided into two groups on the basis of fluorescence. In the 
first group,  which  we called  negative,  the  cytoplasm of the  cells usually  ap- 
peared  dull  orange-brown  almost  identical  to  the  autofluorescence  seen  in 
unstained  preparations.  The  nuclei  of  cells  in  this  group  always  appeared 
completely dark (Fig.  1).  In the second group,  which  we  called  positive,  we 
could detect apple-green fluorescence in,  or on the surface of, the nucleus and 
occasionally in the cytoplasm. The nuclear fluorescence appeared in three dif- 
ferent  forms:  (a)  discrete  granules  varying in  size  and  number,  but  usually 
averaging one to three per cell (Fig. 2); (b)  diffuse finely granular fluorescence 
of the entire nucleus (Fig. 3a) ; (c) fluorescence of the nuclear rim (Fig. 3b). The 
first type was the most common, but all three types could be seen in the same 
specimen in  some cases.  In  the  positive  cases,  most of the cells on  the slide 
showed some form of fluorescence. In some cases discrete fluorescent granules 
were  seen in  the  cytoplasm as well  as in  the  nucleus.  Control  slides  stained 
with  fluorescein-conjugated  goat-vs.-human  or  goat-vs.-rabbit  antisera,  not 
expected to react with Au(1),  showed neither  intranuclear  nor discrete cyto- 
plasmic fluorescence. Occasionally we observed a pale green diffuse cytoplasmic 
fluorescence  in  both  positive  and  negative  slides  as  well  as  in  some  control 
slides. This was considered nonspecific. 
The indirect  method  of staining  demonstrated fluorescent granules only in 
those preparations that were positive by the direct stain. However, the granules 
were located to a large extent in the cytoplasm and intranuclear particles were 
few.  In some cases  the  nucleus  was  disrupted  and fluorescent granules  were 
dispersed  in  the cytoplasm (Fig. 4a,  b). We interpreted this  to indicate that 
the particles  had been dislodged from the  nucleus by the prolonged washing 
procedure. Therefore, we confined our observations to the direct method. 
Classification of Patients.--Table I  lists the patients on whom liver biopsies 
were performed according  to  their  clinical  diagnosis,  the histologic diagnosis 
made  on  the  liver  specimen,  the  presence  of  Au(1)  in  the  serum,  and  the 310  LOCALIZATION OF  AUSTRALIA ANTIGEN 
presence  of fluorescence.  33  patients  had  a  clinical  and  histologic diagnosis  of 
viral hepatitis including acute infectious, posttransfusion,  chronic recurrent, and 
TABLE I 
Classification of Patients Whose Liver Biopsies  Were Studied 
Number  Number  Number 
Clinical diagnosis  tIistologic diagnosis  of  with  with 
patients  Au(1)  positive  fluorescence 
Infectious hepatitis  Viral hepatitis  9  5  8 
Posttransfusion hepatitis  Viral hepatitis  3  3  3 
Hepatitis  in  drug  users  (ex-  Viral hepatitis  6  4  4 
posure to needles) 
Chronic alcoholism and drug  La~nnec's cirrhosis +  acute  2  0  2 
use  and  chronic inflammation 
Chronic recurrent hepatitis  Chronic active hepatitis  2  1  2 
Chronic anicteric hepatitis  Mild inflammatory changes to  12  10  12 
and Down's syndrome  early postnecrotic cirrhosis 
Chronic anicteric hepatitis,  Chronic hepatitis  1  1  1 
Down's syndrome, and leu- 
kemia 
Postnecrotic cirrhosis  Postnecrotic cirrhosis  1  0  1 
Mental retardation  (institu-  Normal liver  3  1  3 
tionalized) 
Biliary cirrhosis  Biliary cirrhosis  1  0  1 
Biliary atresia  Biliary atresia  1  0  1 
Chronic renal disease,  (re-  Hemosiderosis and  chronic in-  1  i  1 
ceived many blood trans-  flammation 
fusions) 
Chronic renal disease  Normal liver  1  0  0 
Drug toxicity  Toxic hepatitis  3  0  0 
Hepatoma  Hepatoma  1  0  0 
Metastatic malignancy  Carcinoma of colon metasta-  1  0  0 
sized to liver 
Hepatomegaly and jaundice  Adenocarcinoma, ? of bile duct  1  0  1 
origin 
Renal malignancy  Carcinoma of kidney metasta-  1  0  1 
sized to liver 
Fever of unknown origin  Nonspecific necrosis  2  0  0 
Acute alcoholic  Acute alcoholic hepatitis  4  0  0 
Chronic alcoholism  La~nnec's cirrhosis  4  0  0 
Sickle cell disease  Hemosiderosis and intravascu-  1  0  0 
lar sickling 
Totals  61  26  41 
chronic  anicteric  hepatitis.  Two  patients  were  chronic  alcoholics  and  drug 
users who had been exposed to needles.  One patient  had postnecrotic  cirrhosis 
which  was  presumed  to  have  resulted  from previous  viral  hepatitis.  One  pa- COY'NE(ZAVATONE)  ET  AL.  311 
tient with chronic renal disease had received many blood transfusions. The 24 
remaining patients had a variety of other diagnoses. 
Relationship between Fluorescence  and Serum Au(1).--Table II A  gives the 
comparison between the occurrence of fluorescence in  the liver cells and the 
presence of Au(1) in the serum. There were 26 patients who had Au(1) in their 
blood.  24  had  a  diagnosis  of viral hepatitis,  one was  a  patient  with  chronic 
renal  disease who had  received many blood transfusions,  and  the  other  was 
an institutionalized  mentally retarded patient with both Au(1)  and antibody 
to Au(1)  in his serum, but a  histologically normal liver. All  26 patients with 
TABLE  II 
Comparison of Immunoltuorescence with Presence of An(l) and Pathologic Diagnosis 
A. Fluorescence  vs. serum Au(1) 
Number of patients with serum Au(1) 
Fluorescence  Total 
+  0 
+  26  15  41 
0  0  20  20 
Totals  26 
Chi square =  19.58; P value <0.001 
35  61 
B. Fluorescence  vs. hepatitis (histologic  diagnosis) 
Number of patients with hepatitis 
Fluorescence  Total 
+  0 
+  30  11  41 
0  3  17  20 
Totals  33  28  61 
Chi square =  16.05; P value <0.001 
Au(1)  in  their  blood had specific fluorescence in  the  nuclei  of cells  obtained 
from the liver biopsy. In  addition,  15  of the  35  patients  who  did  not  have 
Au(1)  in their blood had fluorescent granules in their liver cells. Six of these 
patients had a histologic diagnosis of viral' hepatitis. Two were alcoholics and 
drug users;  one was a  patient with postnecrotic cirrhosis; two were residents 
of an institution for the mentally retarded and had been exposed repeatedly to 
patients with known hepatitis and Au(1). Two were patients with malignancies 
involving the liver and had undergone surgery. One patient had biliary atresia 
and the other primary biliary cirrhosis. 
Relationship between Fluorescence  and Hepatitis.--Table IIB  gives the com- 
parison between the occurrence of fluorescence and the histologic diagnosis of 
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showed  nuclear  fluorescence.  The  three  patients  with  hepatitis  who  did  not 
have fluorescence were in the recovery phase of their  illness  and did not have 
Au(1)  in  their  serum. 
Results of Repeat Biopsies.--Both patients on whom a repeat biopsy was per- 
formed had Au(1)  in  their  serum  and  acute  hepatitis  at  the  time  of the first 
biopsy.  In both  cases  fluorescent granules  were present  in  the first  specimen. 
In one patient fluorescence was not seen on the second specimen,  taken 4  wk 
after the first biopsy, coincident with clinical improvement and disappearance 
TABLE III 
Tissues and Fluids Tested  for Fluorescence 
Type of specimen  Number of  Number with  Number with 
patients  Au(1) in serum  positive 
fluorescence 
Kidney  2  1  0 
Jejunal  loop  4  4  0 
Lymph node  2  2  0 
Spleen  2  1  1 
Bone marrow  8  6  2 
Testis  1  1  1 
Mesentery  1  1  1 
Adrenal  1  0  0 
Ovary  1  0  0 
Gall bladder  1  0  0 
Lung  1  0  0 
Cancer of lung  1  0  0 
Bile and duodenal drainage  8  4  0 
Seminal fluid  1  1  0 
Total  34  21  5 
of Au(1) from the serum. The other patient had a more prolonged illness with 
persistence  of Au(1)  in his  blood for at least  3  months.  Fluorescent  granules 
were still present in his second biopsy specimen, obtained 6 wk after the initial 
biopsy. 
II.  Tissues Other Than Liver 
Table III lists  the  tissues  and  cells  studied  for fluorescence.  All  the tissues 
studied from D.M.  (the patient with Down's syndrome and acute myelogenous 
leukemia),  taken  immediately  after  death,  showed fluorescence.  The  fluores- 
cence  in  the  liver,  testis,  and  mesenteric  connective  tissue  is  similar  to  that 
found in  the  liver  preparation  from patients  with  hepatitis  in  that  the  three 
patterns  of fluorescence were found in all  these  tissues  (Fig.  5a,  b,  c).  In the 
spleen, however, only a small percentage of the cells showed fluorescence which COYNE(ZAVATONE)  ET  AL.  313 
was mostly in the cytoplasm. The bone marrow specimen, obtained 3 wk prior 
to death and consisting almost entirely of myeloblasts,  did not have fluores- 
cence (Fig. 5d). 
Two of eight bone marrow specimens from patients with  acute or chronic 
hepatitis showed fluorescence confined to the cytoplasm of the cells. These were 
from a  patient with  acute infectious hepatitis with Au(1)  in  the  blood,  and 
from a  mentally retarded institutionalized patient who had both Au(1)  and 
antibody to Au(1). In both of these cases only a small percentage of the cells 
on the slide were involved. 
None of the other tissues studied including buffy coat smears, cells obtained 
from bile, duodenal drainage, and seminal fluid showed fluorescence. Peripheral 
lymphocyte cultures in six patients with chronic hepatitis and Au(1)  in their 
serum also were negative. 
DISCUSSION 
By means of the fluorescent antibody technique, using a specific anti-Au(1) 
antiserum, we have demonstrated fluorescent particles mainly in the nuclei and 
occasionally in the cytoplasm of cells from liver biopsies. Fluorescent particles 
were present in 100% of patients who had Au(1)  in their serum. Fluorescent 
granules occurred in  15 patients who did not have Au(1)  in their blood.  Six 
of these had definite clinical and histologic evidence of acute or chronic hepa- 
titis, and 5 others probably had been exposed to viral hepatitis (Table I). We 
interpret these results to indicate that the fluorescence test is more sensitive in 
detecting Au(1)  than is the precipitin test. An alternative explanation is that 
in some patients there is little or no cellular necrosis and consequently little or 
no antigen is released into the peripheral blood; however, it can be detected in 
the cells. 
The finding of fluorescent granules in one patient with biliary atresia  and 
another patient with biliary cirrhosis (Table I) raises the question of possible 
involvement by viral hepatitis in the pathogenesis of these diseases of the biliary 
system. Biliary atresia as an end result of neonatal hepatitis has been discussed 
by Alpert et al. in their study of patients with trisomy 17-18 (12). 
The presence of three forms of fluorescence indicates that Au(1)  is not re- 
stricted  to  one location within  the  nucleus.  In  most  cases  the  fluorescence 
appeared as one to three small masses within the nucleus corresponding morpho- 
logically to the site of the nucleoli. The finding of fluorescence in the region of 
or in the nucleolus is interesting in view of the studies of Bearcroft and Peachey 
(13,  14). Using cytological and cytochemical methods and electron microscopy 
they found that there was swelling of the nucleolus and an increase in nueleolar 
ribonucleoprotein early in viral hepatitis. They postulated that these changes 
may be concerned with viral synthesis. The three forms of fluorescence which 
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proceeding to the dispersal of granules throughout the nucleus, attachment to 
the nuclear membrane, and eventual appearance in the cytoplasm. 
The appearance of fluorescence in a few cells in two bone marrow specimens 
could be  explained on  the  basis  of phagocytosis of circulating  antigen.  The 
widespread presence of fluorescent particles in the tissues of D.M. may repre- 
sent  either massive invasion by virus in  a  patient who was  critically ill  and 
debilitated or a viral proliferation which was directly related to the leukemic 
process. 
We  believe  that  the  fluorescent  antibody  used  in  this  study  specifically 
identifies Au(1)  for the following reasons.  (a)  The immunologic specificity of 
the  antisera  was  confirmed by  immunodiffusion  and  immunoelectrophoretic 
analysis (8). (b) Fluorescein conjugates of antisera which did not contain anti- 
body to Au(1) failed to produce fluorescence in the positive liver preparations. 
(c) The association between fluorescent particles in the liver and the presence 
of Au(1)  in the serum is highly significant (P <  0.001).  (d)  Most of the liver 
specimens negative for fluorescence were from abnormal livers, suggesting that 
the fluorescent antibody does not detect simply a  nonspecific product of cell 
injury. 
SUMMARY 
We have studied the localization of Australia antigen, a particulate substance 
associated  with  hepatitis,  by means  of  the  fluorescent  antibody  technique. 
Preparations were made from 61 liver biopsy specimens taken from patients 
with infectious hepatitis, serum hepatitis, and a variety of other diseases. When 
tested with  fluorescein-conjugated rabbit  anti-Au(1)  antisera  all  26  patients 
who had Au(1) in their serum had specific fluorescence in their liver cells.  The 
fluorescence appeared in three forms: as discrete particles within the nucleus, 
diffuse fluorescence of the entire nucleus,  and fluorescence of the nuclear rim. 
Occasionally there were also fluorescent particles in the cytoplasm. Other speci- 
mens were tested with the fluorescent antibody including a variety of human 
tissues, buffy coat smears, peripheral lymphocyte cultures, and ceils  obtained 
from bile  and  duodenal  drainage.  Among  these  specimens,  fluorescence was 
found in the cytoplasm of a few cells in the bone marrow of two patients with 
hepatitis  and Au(1)  in their serum,  and in the liver, spleen,  mesentery, and 
testis of one patient with leukemia, chronic hepatitis, and Au(1) in his serum. 
We have shown that  the presence of fluorescent particles in the liver ceils  is 
strongly associated with the presence of Au(1) in the serum and the diagnosis of 
viral hepatitis. We believe that this study adds support to the hypothesis that 
Australia  antigen  is  an  antigenic  determinant  of a  virus  capable  of causing 
hepatitis. 
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316 FIG. 2a and b. Cells from liver biopsy of a patient with chronic anicteric hepatitis 
who had Au(1) in his peripheral blood. The biopsy is stained with conjugated rabbit 
anti-Au(1) antiserum, and shows~  intranuclear fluorescent particles. This is scored as 
positive fluorescence.  (a)  phase;  (b)  ultraviolet.  )<  1700. 
Fro. 3. Liver preparations from two patients with viral hepatitis who had Au(1) in 
their  peripheral  blood.  The  biopsy  is  stained  with  conjugated  rabbit  anti-Au(1) 
antiserum. (a) Diffuse fluorescence of entire nucleus. (b) Fluorescence of nuclear rim, 
as well as intranuclear particles.  X  1350. 
317 FIG. 4. Liver preparation from a patient with viral hepatitis stained by the indirect 
method. (a) Stained with uneonjugated rabbit anti-Au(1) antiserum. (b) Stained with 
unconjugated normal  rabbit serum.  ×  1700. 
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